Getinge B, SE0000202624

Getinge B strategy in medical technology, shares anchored in the healthcare sector

Published on 06/28/2026 at 10:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Getinge B is a long-established Swedish medical technology group with a focus on life-supporting equipment and hospital solutions. The stock sits in the healthcare sector alongside peers such as Siemens Healthineers and Philips.

Getinge B, SE0000202624, Illustration mit AI erstellt.
Getinge B, SE0000202624, Illustration mit AI erstellt.

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-28, 10:23.

Getinge B (SE0000202624) represents the Swedish medical technology group Getinge AB, a long-standing supplier of equipment and systems for hospitals and life science laboratories. The stock is part of the European healthcare equipment universe, where investors often compare it with peers such as Siemens Healthineers and Koninklijke Philips.

What current sources show

The official Getinge investor relations site provides the core information about the company, its financial calendar, and its strategic positioning in the healthcare technology market. As of the latest publicly available data, Getinge continues to present itself as a provider of therapy, efficiency, and infection control solutions for clinical and laboratory environments.

Coverage from international financial platforms places Getinge in the broader European medical technology peer group, alongside other equipment manufacturers who support hospitals and clinics with critical devices. This sector classification anchors Getinge shares in the healthcare equipment and services segment, a category that includes imaging, monitoring, and surgical technology providers.

Sunday focus on background and management

On a Sunday, many investors look beyond short-term price moves and instead review the longer-term background and management profile of companies such as Getinge. The group’s leadership has historically emphasized a combination of clinical effectiveness, workflow efficiency, and regulatory compliance across its product lines.

In the healthcare sector, business models like Getinge’s have to navigate strict regulatory frameworks in Europe, North America, and Asia, which shape product development cycles and market access. The management’s ability to align innovation with compliance, while maintaining cost discipline, is a key factor in the long-term attractiveness of medical technology stocks for institutional and retail investors.

Go deeper

Background and price data on Getinge B

Further company information, filings and market data on the Getinge B shares can be found in the ad-hoc-news topic hub and on the company’s own investor relations pages.

How Getinge earns its money

Getinge AB generates revenue by supplying hospitals and life science institutions with medical devices and systems designed for acute care, surgical workflows, and infection control. Typical product lines include ventilators, anesthesia machines, surgical tables, and sterilization units used in operating rooms and central sterile supply departments.

Where the stock trades today

The Getinge B shares (SE0000202624) are listed on Nasdaq Stockholm, where they trade in Swedish kronor alongside other Swedish industrial and healthcare names. The most recent live-verifiable price and timestamp are not available in this dataset, but the shares remain actively traded on the Stockholm exchange.

Key data on the Getinge B shares

  • Company: Getinge AB
  • ISIN: SE0000202624
  • WKN: not available
  • Ticker: GETI B
  • Trading venue: Nasdaq Stockholm
  • Price (as of not available): not available SEK
  • Market cap: not available (as of not available)
  • Sector / industry: Healthcare equipment and supplies
  • Index membership: member of Swedish equity indices that include healthcare equipment companies
  • Next earnings date: not officially scheduled

More on the Getinge B shares in social media

Disclaimer: This text is for information purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. All data are based on sources believed to be reliable but may be subject to change.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | SE0000202624 | GETINGE B | boerse | 69645172 | bgmi